Cybin’s psychedelic drug formualtion will target Alcohol Use Disorder

Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003

Cybin announced that its proprietary new chemical entity (NCE), CYB003, will target Alcohol Use Disorder in response to increased alcohol use during the pandemic. CEO Doug Drysdale is optimistic that CYB003 will provide “a durable respite from alcohol dependence and the potential to overcome this often-crippling disease”.

PDF of article